EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prognostic value of tumor-infiltrating lymphocytes in colon cancer

Bacha Dhouha, Khessairi Neyssem, Kammoun Neirouz, Siala Hager, Lahmar Ahlem, Gharbi Lassad, Ben Slama Sana

Indian Journal of Pathology and Microbiology · 2026

DOI: 10.4103/ijpm.ijpm_710_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Pathology and Microbiology, 2026. Verfasst von Bacha Dhouha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University Hospital Mongi Slim, La Marsa, Tunisia. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Colonic Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Several clinico-pathological prognostic factors are essential to guide therapeutic management for colon cancer (CC). The benefit of adjuvant chemotherapy remains controversial for patients with stage II CC and is currently not systematically applied. This leads to define two subgroups of patients, “low” and “high risk” of recurrence. In this setting, tumor-infiltrating lymphocytes (TILs) may represent a promising marker.

Aims

Our study aimed to assess the prognostic value of TILs in stage II CC. Materials and Methods: We conducted a retrospective study involving the patients who underwent curative surgery for primary stage II colonic adenocarcinoma. The data were collected over a period of 15 years.

Results

Seventy patients were included. The mean age of the patients was 60 years. The most frequent circumstances of discovery were abdominal pain (48%), followed by digestive transit disorders (26%) and digestive bleeding (20%). All patients at “high risk” of recurrence had received adjuvant chemotherapy except for seven patients. The mean overall survival and recurrence-free survival rates were 51 and 56 months, respectively. TILs rate varied between 3% and 80% with a median of 50%. TIL rates < 50% significantly decreased recurrence-free survival in univariate analysis ( P = 0.001). In multivariate analysis, it was identified as an independent factor for the recurrence-free survival. We found a correlation between the rate of TILs < 50% and the lymphatic invasion ( P = 0.022), the high grade of the tumor ( P = 0.02) and the tumor size >3 cm ( P = 0.009).

Conclusion

TILs represent an important prognostic and predictive factor for stage II CC. It should be introduced in clinical practice to identify patients with “high-risk” stage II CC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocytes, Tumor-InfiltratingColonic NeoplasmsAdenocarcinomaHumansFemalePrognosisRetrospective StudiesMaleMiddle AgedAgedAged, 80 and overAdultChemotherapy, AdjuvantNeoplasm Staging

Stichwörter der Autor:innen

Adenocarcinomacolon cancerinfiltrating lymphocytes

Autor:innen und Institutionen

  • Department of Pathology, University Hospital Mongi Slim, La Marsa, Tunisia.
  • University of Tunis El-Manar, Tunis, Tunisia.
  • Department of Surgical Oncology, Salah Azaiez Institute, Tunis, Tunisia.
  • Department of Visceral Surgery, University Hospital Mongi Slim, La Marsa, Tunisia.

Zitieren

APA

Dhouha, B., Neyssem, K., Neirouz, K., Hager, S., Ahlem, L., Lassad, G., & Sana, B. S. (2026). Prognostic value of tumor-infiltrating lymphocytes in colon cancer. Indian Journal of Pathology and Microbiology. https://doi.org/10.4103/ijpm.ijpm_710_24

Vancouver

Dhouha B, Neyssem K, Neirouz K, Hager S, Ahlem L, Lassad G, et al. Prognostic value of tumor-infiltrating lymphocytes in colon cancer. Indian Journal of Pathology and Microbiology. 2026. doi:10.4103/ijpm.ijpm_710_24

BibTeX
@article{Dhouha2026,
  author = {Dhouha, Bacha and Neyssem, Khessairi and Neirouz, Kammoun and Hager, Siala and Ahlem, Lahmar and Lassad, Gharbi and Sana, Ben Slama},
  title = {Prognostic value of tumor-infiltrating lymphocytes in colon cancer},
  journal = {Indian Journal of Pathology and Microbiology},
  year = {2026},
  doi = {10.4103/ijpm.ijpm_710_24}
}
Kostenlos starten →